Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
BankFinancial CORPBankFinancial Corporation Reports $4.1 Million Net Income for Fiscal Year 2024
INTELLIGENT PROTECTION MANAGEMENT CORP.Intelligent Protection Management Corp. Reports 14.2% Revenue Growth but Increased Net Loss in Latest 10-K Filing
SKYX Platforms Corp.SKYX Platforms Corp. Reports 47% Revenue Growth to $86.3 Million for Fiscal Year 2024
PSYCHEMEDICS CORPPsychemedics Reports 11% Revenue Decline to $19.7 Million for Fiscal Year 2024
Artiva Biotherapeutics, Inc.Artiva Biotherapeutics Reports $65.37 Million Net Loss for 2024, IPO Proceeds Boost Cash Reserves
AmBase CorpAmBase Corporation Reports $6.62 Million Net Loss for Fiscal Year 2024
Designer Brands Inc.Designer Brands Inc. Reports 2.1% Net Sales Decline and $10.5 Million Loss for Fiscal Year Ending February 1, 2025
Quince Therapeutics, Inc.Quince Therapeutics Reports $56.8 Million Net Loss for 2024, Driven by Increased Operating Expenses
VEEVA SYSTEMS INCVeeva Systems Reports $2.75 Billion Revenue with 16% Growth for Fiscal Year Ending January 31, 2025
FLYEXCLUSIVE INC.FlyExclusive Reports $21.1 Million Net Loss for 2024, Revenue Increases 3.8%
Innovative Eyewear IncInnovative Eyewear Reports 42% Revenue Growth to $1.64 Million for Fiscal Year 2024
Clene Inc.Clene Inc. Reports $39.4 Million Net Loss for 2024, Revenue Decreases by 48%
ZeroStack Corp.Flora Growth Corp. Reports Revenue Decline to $59.5 Million and Net Loss Improvement for Fiscal Year 2024
Neurogene Inc.Neurogene Inc. Reports $75.1 Million Net Loss for 2024 Amid Rising Operating Expenses
INTELLINETICS, INC.Intellinetics Reports 6.7% Revenue Growth to $18.02 Million, Faces Net Loss
New Concept Energy, Inc.New Concept Energy Reports Decrease in Revenue and Net Loss for Fiscal Year 2024
VIVOS INCVivos Inc. Reports Revenue Increase to $27,995 but Continues to Operate at a Loss
NEPHROS INCNephros Reports Slight Revenue Decline but Achieves First Profitability in 2024
BBX Capital, Inc.BBX Capital Reports $63.9 Million Net Loss and 23.4% Revenue Decline for 2024
ACTELIS NETWORKS INCActelis Networks Reports 38% Revenue Growth to $7.76 Million for Fiscal Year 2024
NOMAD POWER SOLUTIONS, INC.Lixte Biotechnology Reports $3.6 Million Net Loss for 2024, Seeks Additional Funding
Lucid Diagnostics Inc.Lucid Diagnostics Reports $4.3 Million Revenue for Fiscal Year 2024, Faces $45.5 Million Net Loss
Centessa Pharmaceuticals plcCentessa Pharmaceuticals Reports $235.7 Million Net Loss for 2024, Discontinues Key Programs
Lexeo Therapeutics, Inc.Lexeo Therapeutics Reports $98.3 Million Net Loss for Fiscal Year 2024
Evofem Biosciences, Inc.Evofem Biosciences Reports $8.9 Million Net Loss for 2024 Amid Revenue Growth and Ongoing Legal Disputes